Osimertinib
Drug timelines are a Plus or Pro feature.
109 regulatory and trial events tracked for Osimertinib, covering 2015-11-04 to 2026-06-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer [Phase 3]